EP300 and breast cancer: Moreover, Darvin P et al. observed a consistent overexpression of HDAC1 and p300/CBP enzymes in breast cancer cells, which exhibited a close relationship with upregulated PD-L1 level and increased breast cancer aggressiveness (41).